Home » Topics » BioWorld Science

BioWorld Science
RSS

NexImmune advances early-stage programs

March 10, 2022

Immunoprecise reports in vivo data on PolyTope TATX-03 antibody cocktail therapy

March 10, 2022

FDA grants orphan drug designation to BRD9 degrader CFT-8634 for soft tissue sarcoma

March 10, 2022

TRUE CART therapy shows promise in solid tumors

March 10, 2022

SKLB-0322 shows potent antitumor activity in models of ovarian cancer

March 10, 2022

IRAK4 as immunotherapeutic target in pancreatic ductal adenocarcinoma

March 10, 2022

Viva Star Biosciences synthesizes new LPAR1 antagonists

March 10, 2022

Study casts new light on autoimmune disease etiology

March 10, 2022

Bolt Biotherapeutics presents new antibody-drug conjugates

March 10, 2022

Prelude Therapeutics identifies CDK9 inhibitors

March 10, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
Janssen Pharmaceutica reports new TMEM175 activators
BioWorld Science
Janssen Pharmaceutica NV has identified new endosomal/lysosomal proton channel TMEM175 activators that are potentially useful for the treatment of Parkinson’s...
Cancer specter looming, Abtect effect in UC wallops Abivax
BioWorld
Although analysts liked the data – calling them “truly amazing” and “transformational” – Wall Street apparently had qualms about three cancer cases that turned up...
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...